Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Author: mariavikmon

December 5, 2023 CD as API / Pharma applications

Molecular Mind Games: The Medicinal Action of Cyclodextrins in Neurodegenerative Diseases

This work presents the most recent advances in the research and clinical use of HPβCD against Niemann–Pick disease, a congenital

Continue reading

November 22, 2023 Drug delivery / Pharma applications

Cyclodextrins: prospective nanocarriers for the delivery of antibacterial agents, against bacteria  that are resistant  to antibiotics

A review with 303 references Several different kinds of cyclodextrin nanocarriers (β-CD, HP-β-CD, Meth-β-CD, cationic CD, sugar-grafted CD) are utilized

Continue reading

November 15, 2023 Drug delivery / Pharma applications

Stabilization effects of saccharides in protein formulations: A review of sucrose, trehalose, cyclodextrins and dextrans

Saccharides are a popular group of stabilizers in liquid, frozen and freeze dried protein formulations. The current work reviewed the

Continue reading

November 10, 2023 Food

The protective effect of cyclodextrin on color quality and stability of Cabernet Sauvignon red wine

The impact of cyclodextrins (CDs) on wine quality and stability has been seldomly reported. This study systematically assessed the protective

Continue reading

August 21, 2023 Non-pharma applications / Other industrial use

Cyclodextrin to boost flow battery

Redox flow batteries have a unique architecture that potentially enables cost-effective long-duration energy storage to address the intermittency introduced by

Continue reading

August 8, 2023 CD derivatives / Drug delivery / Pharma applications

Cyclodextrins as building blocks for new materials; Special issue in Beilstein J. Org. Chem.

The present thematic issue aims to offer a wide and advanced collection of papers on the use of cyclodextrins as

Continue reading

July 31, 2023 Drug delivery / Pharma applications

Can the Oral Bioavailability of the Discontinued Prostate Cancer Drug Galeterone Be Improved by Processing Method? KinetiSol® Outperforms Spray Drying in a Head-to-head Comparison

Galeterone, a novel prostate cancer candidate treatment, was discontinued after a Phase III clinical trial due to lack of efficacy.

Continue reading

July 25, 2023 CD as API / Pharma applications

Long-term administration of intravenous Trappsol® Cyclo™ (HP-β-CD) in Niemann-Pick disease type C1: Results of an international 48-week Phase I/II trial

Niemann-Pick disease type C (NPC) is a rare, fatal, pan-ethnic, autosomal recessive lysosomal storage disease characterized by progressive major organ

Continue reading

June 21, 2023 Drug delivery / Pharma applications

Comparative evaluation of lyophilized voriconazole formulations marketed in European Union

Voriconazole is an antifungal derived from the structure of fluconazole and is designed to increase the efficacy and spectrum of

Continue reading

June 7, 2023 Drug delivery / Pharma applications

Crystallization inhibition by methylated cyclodextrin

In this study, we investigated the effect of CD derivatives on stabilizing the supersaturation by inhibiting the crystallization of two

Continue reading

Posts navigation

1 2 3 … 16 Next Posts»

Recent Posts

  • The special issue deadline has been extended
  • Phase III Results of Adamgammadex
  • Comparison of cholesterol complexation with β-cyclodextrin derivatives: A combined theoretical and experimental study
  • Molecular Mind Games: The Medicinal Action of Cyclodextrins in Neurodegenerative Diseases
  • Geographical variation of gut microflora shows diversity in catabolizing alpha-cyclodextrin

Tags

alpha-CD Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food Gilead HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (18)
  • Analysis (40)
  • CD as API (236)
  • CD derivatives (290)
  • Cosmetics and toilettry (23)
  • Diagnosis (3)
  • Drug delivery (513)
  • E-ducation (59)
  • Environmental (85)
  • Events (176)
  • Food (147)
  • Gene delivery (12)
  • In Hungarian (4)
  • Life sciences (26)
  • Non-pharma applications (260)
  • Other industrial use (74)
  • Pharma applications (804)
  • Supramolecular systems (30)
  • Uncategorized (64)

Top Posts

  • Australian company pioneering Cavadextrin for regression of atherosclerosis
  • Phase III Results of Adamgammadex
  • 16th Annual World Cancer Congress
  • Wasabi's bioactive component 6-MSITC formulated with alfa-cyclodextrin improved memory proven in clinical trial.
  • Lanosterol eye drops for cataract treatment
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Chemical modification of β-cyclodextrin towards hydrogel formation
  • Symposium of Drug Delivery Systems
  • Comparison of Selective Relaxant Binding Agent Adamgammadex Sodium with Sugammadex for Reversing Rocuronium-Induced Deep Neuromuscular Block
  • The special issue deadline has been extended

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 570 other subscribers
 

Loading Comments...